Crossmark

The prognostic influence of hospital type, method of first histological confirmation and time to chemotherapy in patients with advanced primary ovarian cancer

Crossref DOI link: https://doi.org/10.1007/s00404-024-07832-4

Published Online: 2024-12-16

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Starke, Olivia

Wimberger, Pauline

Klotz, Daniel Martin https://orcid.org/0000-0001-7696-9043
Funding

Funding for this research was provided by:

Technische Universität Dresden
License Information

Text and Data Mining valid from 2024-12-16

Version of Record valid from 2024-12-16
More Information

Article History

Received: 28 May 2024

Accepted: 8 November 2024

First Online: 16 December 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below